General Information of Drug Transporter (DT)
DT ID DTD0257 Transporter Info
Gene Name SLC2A2
Transporter Name Glucose transporter type 2, liver
Gene ID
6514
UniProt ID
P11168
Microbiota Influence of This DT (MBI)

Bacteria: Bacillota

   Genus: Faecalibacterium

     Faecalibacterium prausnitzii 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Down regulating of SLC2A2 expression in gastrointestinal disturbances expression in children with autism condition [1]

Regulation Mechanism

via modulation of the Homeobox protein CDX-2 (CDX2) Transcription Factor Info

Studied Phenotype

Gastrointestinal disturbances [ICD11: 1A40]

Studied Tissue

Ileum

In Vivo Model

Children with autistic disorder and GI disease

Detailed Description

The Faecalibacterium prausnitzii has been reported to decrease the expression of the drug transporter SLC2A2.

Bacteria: Bacteroidota

   Genus: Phocaeicola

     Bacteroides Vulgatus 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

Down regulating of SLC2A2 expression in gastrointestinal disturbances expression in children with autism condition [1]

Regulation Mechanism

via modulation of the Homeobox protein CDX-2 (CDX2) Transcription Factor Info

Studied Phenotype

Gastrointestinal disturbances [ICD11: 1A40]

Studied Tissue

Ileum

In Vivo Model

Children with autistic disorder and GI disease

Detailed Description

The Bacteroides Vulgatus has been reported to decrease the expression of the drug transporter SLC2A2.

   Genus: Prevotella

     Prevotella copri 

Microbe Info

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence 1

Up regulating of SLC2A2 expression in the health condition [2] , [3]

Regulating Factor

Short-chain fatty acid (Acetate)

Studied Tissue

Ileum

In Vivo Model

Sprague-Dawley rats

Detailed Description

The metabolite short-chain fatty acid (acetate) generated from the metabolism of dietary food by the Prevotella copri has been reported to increase the expression of the drug transporter SLC2A2.

       Microbe Influence 2

Up regulating of SLC2A2 expression in the health condition [2] , [3]

Regulating Factor

Short-chain fatty acid (Butyrate)

Studied Tissue

Ileum

In Vivo Model

Sprague-Dawley rats

Detailed Description

The metabolite short-chain fatty acid (butyrate) generated from the metabolism of dietary food by the Prevotella copri has been reported to increase the expression of the drug transporter SLC2A2.

       Microbe Influence 3

Up regulating of SLC2A2 expression in the health condition [2] , [3]

Regulating Factor

Short-chain fatty acid (Propionate)

Studied Tissue

Ileum

In Vivo Model

Sprague-Dawley rats

Detailed Description

The metabolite short-chain fatty acid (propionate) generated from the metabolism of dietary food by the Prevotella copri has been reported to increase the expression of the drug transporter SLC2A2.

Bacteria: Host unspecified microbiota

   Genus: Unknown microbiota

     Host unspecified microbiota 

Click to Show/Hide the Full List 5 Microbe Influence Related to This Species      

       Microbe Influence 1

Up regulating of SLC2A2 expression in colon cancer condition [4]

Regulating Factor

Butyrate

Studied Phenotype

Colon cancer [ICD11: 2B90]

Studied Tissue

Colon

In Vitro Model

Human colon adenocarcinoma cells (Caco2-BBE)

Detailed Description

The metabolite butyrate generated from the metabolism of dietary food by the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC2A2.

       Microbe Influence 2

Up regulating of SLC2A2 expression in the health condition [5]

Regulating Factor

7-Sulfocholic acid

Studied Tissue

Liver

In Vivo Model

C57BL/6J mice

Detailed Description

The metabolite 7-sulfocholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC2A2.

       Microbe Influence 3

Up regulating of SLC2A2 expression in the health condition [5]

Regulating Factor

Muricholic acid

Studied Tissue

Liver

In Vivo Model

C57BL/6J mice

Detailed Description

The metabolite muricholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC2A2.

       Microbe Influence 4

Up regulating of SLC2A2 expression in the health condition [5]

Regulating Factor

Taurocholic acid

Studied Tissue

Liver

In Vivo Model

C57BL/6J mice

Detailed Description

The metabolite taurocholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC2A2.

       Microbe Influence 5

Up regulating of SLC2A2 expression in the health condition [5]

Regulating Factor

Taurodeoxycholic acid

Studied Tissue

Liver

In Vivo Model

C57BL/6J mice

Detailed Description

The metabolite taurodeoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC2A2.
References
1 Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One. 2011;6(9):e24585.
2 Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats. Gastroenterology. 1997 Mar;112(3):792-802.
3 Systemic short-chain fatty acids rapidly alter gastrointestinal structure, function, and expression of early response genes. Dig Dis Sci. 1998 Jul;43(7):1526-36.
4 Glucagon-like peptide-2 and short-chain fatty acids: a new twist to an old story. J Nutr. 2003 Nov;133(11):3717-20.
5 Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism. Microbiome. 2017 Aug 9;5(1):95.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.